Immune Thrombocytopenia
📧 Sign up to get email alerts when something new happens for Immune Thrombocytopenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 1]
Phase 1 trial evaluating the safety and efficacy of Hetrombopag Olamine in patients with immune thrombocytopenia (ITP), sponsored by Jiangsu…
-
FDA approval · 2015-08-24FDA Approved: PROMACTA — Original Application (Novartis Pharmaceuticals Corporation)
FDA approved PROMACTA (eltrombopag olamine) in its original application for the treatment of immune thrombocytopenia. This represents the in…
-
CLINICAL_TRIALS trial_result · 2015-08-18Clinical Trial Update: The Role of Traditional Chinese Medicine in the Treatment of Chronic Childhood Immune Thrombocytopenia (ITP) [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Traditional Chinese Medicine for childhood chronic immune thrombocytopenia was terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: NATURAL KILLER CELLS IN IMMUNOLOGIC THROMBOCYTOPENIC PURpura of Adults [NA]
This clinical trial update reports on a completed study investigating natural killer cells in adults with immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS research · 2015-03-31Clinical Trial Update: A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients [Phase 1]
A Phase 1 clinical trial evaluating hetrombopag olamine for chronic immune thrombocytopenia (idiopathic thrombocytopenic purpura).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-03-12Clinical Trial Update: A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) [Phase 4]
A Phase 4 longitudinal study evaluating eltrombopag over two years in adults with chronic immune thrombocytopenia who had prior treatment; t…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: A Study of MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura. [Phase 2]
Phase 2 study evaluating rituximab (MabThera) in patients with immune thrombocytopenia has completed enrollment, with results posted in Febr…
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP [Phase 2]
A Phase 2 observational study evaluating the efficacy of biweekly romiplostim in adult patients with immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura [EARLY_Phase 1]
Phase 1 study evaluating rituximab plus prednisone as first-line therapy for immune thrombocytopenia has been completed.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body. [Phase 3]
Phase 3 trial in children with immune thrombocytopenia (Idiopathic Thrombocytopenic Purpura) evaluating a new medication has completed. Resu…
-
FDA approval · 2014-08-26FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PROMACTA (eltrombopag olamine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP [Phase 2]
Phase 2 trial update reporting results of rapid intravenous immunoglobulin (IVIG) infusion in patients with immune thrombocytopenia.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Pilot Study of Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
Phase 2 trial completed evaluating fostamatinib disodium (R935788) for adult patients with refractory immune thrombocytopenia (ITP). Results…
-
CLINICAL_TRIALS withdrawal · 2014-07-28Clinical Trial Update: A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia. [Phase 2]
A Phase 2 clinical trial evaluating belimumab for chronic immune thrombocytopenia was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults [Phase 3]
Phase 3 clinical trial evaluating Octagam 10% for immune thrombocytopenia in adults has completed. Results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: Nexium Capsules Helicobacter Pylori Specific Clinical Experience Investigation
A completed trial update evaluating Nexium (esomeprazole) for Helicobacter pylori–specific clinical experience across several gastric diseas…
-
CLINICAL_TRIALS trial_result · 2014-03-26Clinical Trial Update: Rituximab as Second Line Treatment for ITP [Phase 3]
Phase 3 clinical trial evaluating rituximab as second-line treatment for immune thrombocytopenia has completed.
-
FDA approval · 2014-02-10FDA Approved: PROMACTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for PROMACTA (eltrombopag olamine) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP)
A completed clinical trial evaluating health-related quality of life and fatigue in adults with primary immune thrombocytopenia (ITP).
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT [Phase 2]
This report covers a Phase 2 trial evaluating eltrombopag with high-dose dexamethasone as first-line therapy for immune thrombocytopenia. Th…
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: A Study to Evaluate the Relative Bioavailability and Intra-Subject Variability of Two Lots of E5501 40 mg Tablets Administered Twice as Single Oral Doses to Healthy Subjects [Phase 1]
Phase 1 study to evaluate the relative bioavailability and intra-subject variability of two lots of E5501 40 mg tablets in healthy subjects …
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Immunoglobulins Anti Platelets In Breast Milk Of Maternal ITP
This is a clinical trial update evaluating immunoglobulins targeting platelets in the breast milk of mothers with immune thrombocytopenia (I…
-
FDA approval · 2013-05-30FDA Approved: NPLATE — Supplemental Application (Amgen, Inc)
The FDA approved a supplemental application for NPLATE (romiplostim) from Amgen, Inc.
-
CLINICAL_TRIALS trial_result · 2013-04-15Clinical Trial Update: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) [Phase 2]
A Phase 2 trial evaluating SB-497115, an oral thrombopoietin receptor agonist, versus placebo in adults with refractory immune thrombocytope…
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Efficacy and Safety Study of Maintenance Treatment With rhTPO in Thrombocytopenic Subjects With ITP [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of maintenance treatment with recombinant human thrombopoietin (rhTPO) in patients…